| COVID-19 |
1 |
0.9 |
| Lipids Management |
0 |
0.67 |
| Fatty Acids |
0 |
0.49 |
| Geriatrics |
0 |
0.47 |
| Lymphocytes |
0 |
0.42 |
| Cytokines |
0 |
0.35 |
| Intravenous |
0 |
0.35 |
| Atrial Fibrillation |
0 |
0.34 |
| Concerns of Elderly |
0 |
0.32 |
| Brachial |
0 |
0.21 |
| Meta-Analysis |
0 |
0.21 |
| Neutrophils |
0 |
0.21 |
| Cardiovascular Risk Management |
0 |
0.17 |
| Biologic Therapy |
0 |
0.14 |
| Fish Oil |
0 |
0.14 |
| C-Reactive Protein (CRP) |
0 |
0.12 |
| White Blood Cell Count |
0 |
0.1 |
| Medical Life |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.08 |
| Allergy |
0 |
0.07 |
| Biomarker |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Clinician Health and Well-Being |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Health Care Quality, Access, and Evaluation |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Immunocompromise |
0 |
0.07 |
| Interleukin |
0 |
0.07 |
| Metabolism |
0 |
0.07 |
| Physiology |
0 |
0.07 |
| Respiratory Failure |
0 |
0.07 |
| Shock |
0 |
0.07 |